BDBM531771 (�)-2-(6-{[1-(cyclopropylmethyl)-3-(4-fluorophenyl)-4-methyl-1H-pyrazol-5-yl]amino}pyrimidin-4-yl)-3,4-dimethyl-2,4,5,6-tetrahydrocyclopenta[c]pyrazol-4-ol (Racemate)::US11208400, Example 404::US11208400, Example 515::US11208400, Example 516

SMILES O=C1CCC(N2Cc3cc(C(O)C4(O)CN(Cc5ccccc5-c5ccc(Cl)cc5)C4)ccc3C2=O)C(=O)N1

InChI Key InChIKey=REYUAUVQHMFDRA-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 531771   

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 531771BDBM531771(3-(5-((1-((4'-chloro-[1,1'-biphenyl]-2- yl)methyl)...)
Affinity DataIC50: 230nMAssay Description:Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRIMSC) Affiliation: The Scripps Research Institute, TSRI Assa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2026
Entry Details US Patent